A. “Diagnosed Mild Cognitive Impairment Due to Alzheimer’s Disease with PET Biomarkers of Beta Amyloid and Neuronal Dysfunction,” by Shizuo Hatashita and Hidetomo Yamasaki (PLoS ONE 8(6): e66877. doi:10.1371/journal.pone.0066877, XML, HTML, and .pdf format, 6p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0066877
B. “Evaluating Amyloid-{beta} Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer’s Disease,” by Mikko Holtta, Oskar Hansson, Ulf Andreasson, Joakim Hertze, Lennart Minthon, Katarina Nagga, Niels Andreasen, Henrik Zetterberg, and Kaj Blennow (PLoS ONE 8(6): e66381. doi:10.1371/journal.pone.0066381, XML, HTML, and .pdf format, 8p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0066381
C. “Risk Factors for Late-Life Cognitive Decline and Variation with Age and Sex in the Sydney Memory and Ageing Study,” by Darren M. Lipnicki, Perminder S. Sachdev, John Crawford, Simone Reppermund, Nicole A. Kochan, Julian N. Trollor, Brian Draper, Melissa J. Slavin, Kristan Kang, Ora Lux, Karen A. Mather, and Henry Brodaty (PLoS ONE 8(6): e65841. doi:10.1371/journal.pone.0065841, XML, HTML, and .pdf format, 9p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0065841
